Cancer antigen, cancer therapy, and cancer diagnosis

Details Cancer antigen, cancer therapy, and cancer diagnosis Cancer antigen, cancer therapy, and cancer diagnosis

1975-10-28

1979-01-02

Padgett, Benjamin R.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Molecular bilayer structure

424 9, 260112R, 206569, 23230B, A61K 2900, A61K 4300

Patent

active

041327691

ABSTRACT:
A novel human cancer associated protein, termed C1 IAC, having C1 inactivator-like function, diagnostic tests based on demonstrating the presence of C1 IAC, antibodies and antisera with specificity against C1 IAC, matrix-immobilized antibodies, and the therapy of human cancer using antisera or antibodies with specificity against C1 IAC. Also, a novel human cancer associated protein, termed CAAC, and antisera and antibodies with specificity against CAAC. The use of rabbit antihuman C1 IA and antihuman C4 for monitoring cancer diseases.

REFERENCES:
patent: 2165370 (1939-07-01), Gruskin
patent: 3663684 (1972-05-01), Freedman et al.
patent: 3697638 (1972-10-01), Hansen
patent: 3852415 (1974-12-01), Vandervoorde
patent: 3867363 (1975-02-01), Hansen
patent: 3927193 (1975-12-01), Hansen
patent: 3956258 (1976-05-01), Hansen
patent: 3960827 (1976-06-01), Bjorklund

Affiliated with

Also associated with

Rating

Cancer antigen, cancer therapy, and cancer diagnosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer antigen, cancer therapy, and cancer diagnosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer antigen, cancer therapy, and cancer diagnosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1517760